We report on the synthesis and the antimicrobial activity of 9-cyclopropyl-4-fluoro-6-oxo[1,2,5]thiadiazolo[3,4-h]quinoline-5-carboxylic acid (16), representative of a new class of antibacterial agents structurally related to the clinically successful fluoroquinolones. The novel 6-fluoroquinolone (16) is herein prepared, in good yield, by thermal cyclocondensation of ethyl 7,8-diamino-9-cyclopropyl-4-fluoro-6-oxoquinoxaline-7-carboxylate with thionyl chloride, followed by acid-catalysed hydrolysis of the ester intermediate (15). Their structures were characterized by IR, MS, 1 H-and 13 C NMR spectra and X-ray crystal structure of 16 is presented. The antimicrobial evaluation against a broad panel of wild and resistant Grampositive and Gram-negative bacteria and fungal species demonstrated the high antibacterial activity of 16, even at the concentration of 0.015 µg mL -1 .
Introduction
Resistance to currently available antibacterial drugs is bringing alarming threat to public health and causing growing concern among people across the globe. At the same time as the old antibiotics are losing their effectiveness, the supply of new drugs is drying up. Our best weapon against this threat is to continually develop new antibiotics and new synthetic antibacterials against which bacteria have not yet developed resistance.
Several substituted benzo [c] [1,2,5]thiadiazoles 1 ( Figure 1 ) were reported to exhibit diverse bio-pharmacological properties such as insecticidal and acaricidal, 1 fungicidal and nematocidal, [2] [3] [4] antimicrobial 5 or antiviral 6 activities. Quite recently, some derivatives of 1 have been shown to be active as ubiquitin ligase inhibitors. 7 In this respect, it is worth mentioning that benzo [c] [1,2,5]thiadiazole ring system constitutes the skeleton of Tizanidine 2, a muscle relaxant used as antispastic agent for treatment of central nervous system disorders, 8 and for spasticity in multiple sclerosis, stroke, and spinal cord injury. [9] [10] [11] On the other hand, fluoroquinolone-based drugs (e.g. ciprofloxcacin [12] [13] [14] ) represent some of the most effective antiinfectious drugs currently in clinical use. [15] [16] [17] [18] [19] [20] [21] Various types of synthetic thiadiazoloquinolines, e.g. 3 22 and 4, [23] [24] [25] [26] have been reported and recently, synthetic tricyclic system 5, having the thiadiazole moiety [h]-fused to 4-oxoquinoline-3-carboxylic acid, has been shown to be active against several Gram-negative and Gram-positive bacterial strains. 27, 28 Compound 5 was prepared via the traditional Gould-Jacobs In light of these facts, we thought it would be worthwhile to incorporate, into compound 5, a fluorine atom and a cyclopropyl group at C(4)-and C(9)-positions, respectively. Both substituents are expected to give an impetus to the antibacterial potency of 5. Accordingly, we report herein on the synthesis of 9-cyclopropyl-4-fluoro-6-oxo [1, 2, 5] thiadiazolo [3,4-h] quinoline-7-carboxylic acid (16) and its ethyl ester (15) utilizing the diamino compound 14 as outlined in Scheme 1, together with X-ray crystal data of 16 and the results of a detailed antibacterial evaluation of 15 and 16.
Results and Discussion
Chemistry Condensed 1,2,5-thiadiazoles are readily prepared via direct interaction of the appropriate orthodiaminoarene/heteroarene with thionyl chloride. 22, 23, 36 (ii)
Scheme 1. Synthesis of thiadiazolo [3,4-h] C-signal assignments to the different carbons and the neighboring hydrogens. In HMBC experiments, distinct 'three-bond' ( 1 H, 13 C) correlations are observed between H-5 and each of C-3a, C-9a and C-6, and between H-8 and each of C-9a, C-1', C-6 and CO 2 Et/CO 2 H.
Crystallography
The structure of 16 was confirmed by means of the X-ray diffractive analysis of single-crystal. A summary of data collection and refinement parameters is given in Table 1 . Selected bond angles are listed in Table 2 . The molecular structure of 16, based on crystallographic data, is displayed in Figure 3 . Table 2 . Selected bond lengths (Å) and angles (°) for compound 16 bond lengths bond angles
Figure 3. ORTEP plot of the molecular structure of 16. Displacement ellipsoids are drawn at the 50 % probability level.
Antimicrobial assay
The new fluoroquinolone 16 and its ester parent compound 15 were tested in vitro against a wide spectrum of Gram-positive (Table 3) and Gram-negative (Table 4 ) bacteria, yeasts and moulds. The minimum inhibitory concentrations (MIC) and the minimum bactericidal concentrations (MBC), both expressed in µg mL -1 , were determined and compared to those of ciprofloxacin 7 as reference drug (Tables 3 and 4 ). Since the development of new antimicrobial agents is increasingly important due to the continual emergence of microbial strains that demonstrate multidrug resistance, both methicillin-and ciprofloxacin-resistant bacteria were assayed simultaneously.
Compound 16 shows a very strong activity against Gram-positive bacilli and staphylococci (MICs 0.015-1.5 µg mL -1 ), including methicillin-resistant Staphylococcus aureus, and against most of the Gram-negative bacteria tested (MICs 0.07-3 µg mL -1 ). A limited effect is detected for the ester parent compound 15 against the same microorganisms (MICs 3-200 µg mL -1 for Grampositive bacteria and 12-400 µg mL -1 for Gram-negative ones), confirming that the carboxylic group on 7-position is an optimal requirement for the antibacterial potency of these compounds. 27 The spectrum of activity and the degree of efficacy of compound 16 against the different strains of bacteria is similar to that of ciprofloxacin 7, with MIC values identical or higher than those of the reference compound. The only exception is Staphylococcus haemolyticus that is more sensitive to compound 16 than ciprofloxacin. Both 15 and 16 act as bacteriostatic agents, being MBC values always higher than the corresponding MICs. As expected, compound 16, bearing a fluorine atom and a cyclopropyl group at C(4)-and C(9)-positions, respectively, showed increased antibacterial activity when compared with compound 5 (Tables 3 and 4 ). 
28

Conclusions
The 9-cyclopropyl-4-fluoro-6-oxothiadiazolo[3,4-h]quinoline-7-carboxylic acid 16 described herein represents a potential antibacterial agent for treatment of serious Gram-positive and Gram-negative infections. However, this compound still lacks effectiveness against methicillinand quinolone-resistant strains. These results encourage further modifications of the fluorothiadiazoloquinoline scaffold to provide novel compounds more active than the existing quinolones.
Experimental Section
General. Pure grade thionyl chloride, benzene, methanol and dichloromethane were purchased from Acros Organics (Geel, Belgium). Ciprofloxacin used as standard quinolone was obtained from Sigma (Milano, Italy). Melting points (uncorrected) were determined on a Gallenkamp electrothermal melting-temperature apparatus.
1 H-and 13 C NMR spectra were measured on a Bruker DPX-300 instrument. Chemical shifts are expressed in ppm with reference to TMS as internal standard. Electron impact mass spectra (EIMS) were obtained using a Finnigan MAT TSQ-70 spectrometer at 70 eV and at an ion source temperature of 200ºC. High-resolution mass spectra (HRMS) were measured in positive ion mode using electrospray ion trap (ESI) technique by collision-induced dissociation on a Bruker APEX-4 (7 Tesla) instrument. The samples were dissolved in acetonitrile, diluted in spray solution (methanol/water 1:1 v/v + 0.1% formic acid) and infused using a syringe pump with a flow rate of 2 µL/min. External calibration was conducted using Arginine cluster in a mass range m/z 175-871. IR spectra were recorded as KBr discs on a Nicolet Impact-400 FT-IR spectrophotometer (abbreviations: vs = very strong, s = strong, m = medium, w = weak, br = broad). Elemental analyses (C, H, N, S) were performed at the Microanalytical Laboratory of the Hashemite University, Zarqa-Jordan, and the results were found to be in good agreement (± 0.4%) with the calculated values.
Ethyl 3-(N,N-dimethylamino)-2-(2,4-dichloro-5-fluoro-3-nitrobenzoyl)acrylate 13a.
A mixture of 2,4-dichloro-5-fluoro-3-nitrobenzoic acid (10.2 g, 40 mmol) and thionyl chloride (19.0 g, 160 mmol) in dry benzene (120 mL) was refluxed for 3-4 h under anhydrous conditions. The solvent and excess thionyl chloride were then distilled off under reduced pressure, and dry benzene (20 mL) was then introduced into the reaction vessel and re-distilled so as to remove traces of thionyl chloride. The resulting 2,4-dichloro-5-fluoro-3-nitrobenzoyl chloride, formed as thick oil, was used as such for the next step without further purification. To a stirred and cooled (5-10 °C) solution of ethyl 3-(N,N-dimethylamino)acrylate (6.3 g, 44 mmol) and triethylamine (8.1 g, 80 mmol) in dry benzene (50 mL) was added dropwise a solution of the crude acid chloride (prepared above) in dry benzene (25 mL). The resulting mixture was refluxed for 2 h, then cooled to rt and washed with water (2 × 30 mL). The organic layer was separated, dried (anhydrous MgSO 4 ) and the solvent benzene was then evaporated to dryness under reduced pressure. The residual product was soaked in methanol (10 mL) whereby the title compound was produced as yellowish powder which was collected by suction filtration and dried. Yield 13.8 g (91%), mp 140-141 o C (Lit.
42 139-141 o C).
Ethyl 3-(N-cyclopropylamino)-2-(2,4-dichloro-5-fluoro-3-nitrobenzoyl)acrylate (13b).
A stirred solution of 13a (14.4 g, 38 mmol) in dichloromethane (50 mL) and methanol (10 mL), cooled to 8-10 °C, was treated dropwise with cyclopropylamine (3.2 g, 56 mmol) in MeOH (3 mL), and the resulting mixture was further stirred for additional 10-15 min at 8-10 °C. Methanol (90 mL) was then added and the reaction mixture was stirred at rt for 1-2 h. The precipitated white solid product was filtered, washed with cold ethanol (95%, 10 mL) and dried. Yield 11.0 g; a second crop of 13b (1.7 g) was obtained upon concentration of the mother liquor. Total yield 12.7 g (93%), mp 143-145 o C (Lit. 42 142-145 o C).
Ethyl 7-chloro-1-cyclopropyl-6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate (13c). A solution of 13b (11.7 g, 30 mmol) in DMF (50 mL) and potassium carbonate (12.4 g, 90 mmol) was heated at 85 °C. Progress of the cyclisation reaction was monitored by TLC (eluent: AcOEt + n-hexane, 1:1 v/v) and was completed within 90-100 min. The reaction mixture was then poured slowly onto crushed ice (500 g) under vigorous stirring, the precipitated pale yellow solid product was collected, washed with water, triturated with cold ethanol and dried. Ethyl 7-azido-1-cyclopropyl-6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate (13d). Sodium azide (7.8 g, 120 mmol) was added to a solution of 13c (7.1 g, 20 mmol) in dimethylsulfoxide (100 mL). The resulting mixture acquired white turbidity within few minutes, and was further stirred at rt for 6-8 h. Thereafter, the reaction mixture was diluted with cold water (250 mL), and the precipitated solid product was collected under suction, washed with cold water and dried. Yield 5.6 g (78 %), mp 184-185 o C (dec.) (Lit. 38 183-184 o C).
Ethyl 7,8-diamino-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate (14).
Anhydrous stannous chloride (5.3 g, 28 mmol) was added portionwise to a stirred and ice-cooled (4-8 o C) solution of 13d (2.2 g, 6.3 mmol) in 36% aqueous HCl (50 mL). The reaction mixture was further stirred at rt for 24 h, then diluted with ice-cooled water (50 mL), basified with 40% cold aqueous NaOH solution to pH 11-12 and set aside for 10-20 min. The precipitated solid product was collected by suction filtration, washed with cold water, dried and purified by column chromatography on silica gel, using chloroform followed by chloroform / methanol (95:5, v/v) To a stirred suspension of 14 (0.92 g, 3 mmol) in dry toluene (25 mL), was added purified thionyl chloride (6 mL) and the resulting mixture was heated at 80-85 ºC for 8 h. Toluene and excess thionyl chloride were distilled off in vacuo and the residue was cooled, treated with methanol (4 mL); cold water (50 mL) was then added to afford a precipitate, which was collected, dried and purified by recrystallization from dichloromethane/methanol. Yield 0.72 g (72 %), mp [205] [206] [207] o C (yellow needles 
Antimicrobial assay
The in vitro antimicrobial activity was performed by the broth dilution technique 43 against Grampositive and Gram-negative bacteria, yeasts and moulds. The compounds were tested at concentrations ranging from 400 to 0.0007 µg mL -1 . Ciprofloxacin was used as a reference standard. The inoculum size was 5x10 5 bacteria/mL and 1x10 3 fungi/mL. After incubation at 37°C for 24 h (bacteria) or at 30°C for 48 h (fungi), the minimum inhibitory concentration (µg mL -1 ) at which no growth was observed was taken as the MIC value. The minimum bactericidal concentration (MBC, µg mL -1 ) was determined by subculturing in fresh medium 100 µL of liquid from each suspension remaining clear and incubating the sample at 37°C for 24 h. All experiments were performed in triplicate and repeated at least three times.
